Entity Common Stock, Shares Outstanding of Odyssey Health, Inc. from 31 Jul 2015 to 11 Mar 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Odyssey Health, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Jul 2015 to 11 Mar 2026.
  • Odyssey Health, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 11 Mar 2026 was 99,853,763, a 3.3% increase year-over-year.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Odyssey Health, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2026 99,853,763 +3,144,000 +3.3% 11 Mar 2026 10-Q 12 Mar 2026 2026 Q2
Q4 2025 99,853,763 +3,144,000 +3.3% 11 Dec 2025 10-Q 11 Dec 2025 2026 Q1
Q3 2025 99,853,763 +3,144,000 +3.3% 29 Oct 2025 10-K 29 Oct 2025 2025 FY
Q2 2025 96,709,763 +350,000 +0.36% 13 Jun 2025 10-Q 13 Jun 2025 2025 Q3
Q1 2025 96,709,763 +350,000 +0.36% 14 Mar 2025 10-Q 14 Mar 2025 2025 Q2
Q4 2024 96,709,763 +13,585,702 +16% 16 Dec 2024 10-Q 16 Dec 2024 2025 Q1
Q3 2024 96,709,763 +14,975,702 +18% 13 Nov 2024 10-K 13 Nov 2024 2024 FY
Q2 2024 96,359,763 +17,851,884 +23% 14 Jun 2024 10-Q 14 Jun 2024 2024 Q3
Q1 2024 96,359,763 +18,951,884 +24% 22 Mar 2024 10-Q 22 Mar 2024 2024 Q2
Q4 2023 83,124,061 +7,529,907 +10% 15 Dec 2023 10-Q 15 Dec 2023 2024 Q1
Q3 2023 81,734,061 +9,739,907 +14% 30 Oct 2023 10-K 30 Oct 2023 2023 FY
Q2 2023 78,507,879 -6,101,565 -7.2% 14 Jun 2023 10-Q 14 Jun 2023 2023 Q3
Q1 2023 77,407,879 -998,193 -1.3% 17 Mar 2023 10-Q 17 Mar 2023 2023 Q2
Q4 2022 75,594,154 -15,421,496 -17% 14 Dec 2022 10-Q 14 Dec 2022 2023 Q1
Q3 2022 71,994,154 -19,021,496 -21% 31 Oct 2022 10-K 31 Oct 2022 2022 FY
Q2 2022 84,609,444 -12,281,724 -13% 14 Jun 2022 10-Q 14 Jun 2022 2022 Q3
Q1 2022 78,406,072 -21,415,698 -21% 15 Mar 2022 10-Q 15 Mar 2022 2022 Q2
Q4 2021 91,015,650 +445,448 +0.49% 10 Dec 2021 10-Q 10 Dec 2021 2022 Q1
Q3 2021 91,015,650 +445,448 +0.49% 29 Oct 2021 10-K 29 Oct 2021 2021 FY
Q2 2021 96,891,168 +9,720,768 +11% 21 Jun 2021 10-Q 21 Jun 2021 2021 Q3
Q1 2021 99,821,770 +12,631,370 +14% 11 Mar 2021 10-Q 11 Mar 2021 2021 Q2
Q4 2020 90,570,202 +3,579,802 +4.1% 10 Dec 2020 10-Q 11 Dec 2020 2020 Q1
Q3 2020 90,570,202 +3,579,802 +4.1% 13 Nov 2020 10-K 16 Nov 2020 2021 FY
Q2 2020 87,170,400 +18,425,000 +27% 04 Jun 2020 10-Q/A 13 Nov 2020 2020 Q3
Q1 2020 87,190,400 +18,545,000 +27% 12 Mar 2020 10-Q/A 13 Nov 2020 2020 Q2
Q4 2019 86,990,400 06 Dec 2019 10-Q/A 13 Nov 2020 2020 Q1
Q3 2019 86,990,400 23 Oct 2019 10-K/A 13 Nov 2020 2019 FY
Q2 2019 68,745,400 +7,331,400 +12% 07 Jun 2019 10-Q 07 Jun 2019 2019 Q3
Q1 2019 68,645,400 13 Mar 2019 10-Q 14 Mar 2019 2019 Q2
Q2 2018 61,414,000 -53,425,600 -47% 31 Jul 2018 10-K 12 Dec 2018 2018 FY
Q4 2017 114,839,600 +89,600 +0.08% 20 Dec 2017 10-Q 20 Dec 2017 2018 Q1
Q2 2017 114,839,600 +89,600 +0.08% 19 Jun 2017 10-Q 21 Jun 2017 2017 Q3
Q1 2017 114,839,600 +89,600 +0.08% 21 Mar 2017 10-Q 23 Mar 2017 2017 Q2
Q4 2016 114,750,000 0 0% 20 Dec 2016 10-Q 20 Dec 2016 2017 Q1
Q2 2016 114,750,000 0 0% 16 Jun 2016 10-Q 16 Jun 2016 2016 Q3
Q1 2016 114,750,000 14 Mar 2016 10-Q 15 Mar 2016 2016 Q2
Q4 2015 114,750,000 21 Dec 2015 10-Q 22 Dec 2015 2016 Q1
Q2 2015 114,750,000 31 Jul 2015 10-K 01 Dec 2015 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.